Komori
Earnings4369Tri Chemical Laboratories Inc.Materials and Chemicals

Q1 Financial Results for the Fiscal Year Ending January 2027 [Japanese GAAP] (Consolidated)

In the first quarter of the fiscal year ending January 2027, net sales, operating income, ordinary income and net income exceeded the year-earlier period, driven by factors including increased demand from the semiconductor industry. The full-year earnings forecasts and annual dividend forecast remain unchanged from the previous forecasts.

Worth reading
37Immaterial
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
20.8
Year-on-year change in operating income (%)
Wording
Conditional
How definitive the wording is.

Results for this period

First quarter1 February 2026–30 April 2026ConsolidatedJapanese GAAP
Net Sales7,488¥ millionYear on year +14.0%Progress 27.7%
Operating profit2,069¥ millionYear on year +20.8%Progress 34.5%
Ordinary income2,485¥ millionYear on year +51.5%Progress 39.4%
Net income attributable to owners of the parent1,855¥ millionYear on year +53.6%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥57.09
Financial position at period-end
Total assets47,174¥ million
of which net assets 36,761 ¥ millionEquity ratio 77.9%vs. prior year-end +1.4pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+1,776,035
Investment-2,427,221
Financials+1,119,213
Net change+468,027

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥7,797,927 thousand
Segment revenueHigh-Purity Chemical Compounds Business ¥7,488,666 thousand
Regional sales¥1,041,940 thousand, ¥3,018,785 thousand, ¥2,459,526 thousand, ¥690,949 thousand, ¥277,463 thousand
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥27,000 million (YoY +13.1%)
Operating profit¥6,000 million (YoY +1.7%)
Ordinary income¥6,300 million (YoY -11.1%)
Profit attributable to owners of the parent¥4,600 million (YoY -16.6%)
Annual Dividend Forecast¥35 → ¥35(0.0%)
Factors Behind Changes in Business Performance

Demand for high-purity chemical compounds used in semiconductor manufacturing increased due to expanded data center investment accompanying the spread of generative AI, sustained investment in advanced logic and memory, and increased inventories held by Chinese customers. Profitability was improved through cost reductions, sales price revisions, and deeper collaboration among group companies and departments, while ordinary income increased due to the recognition of equity-method investment gains and other factors.

Disclosure regarding the going concern assumption

None (the note on the going concern assumption states, “There are no applicable matters.”)

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Depreciation and amortization¥604,611 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End32,498,640 Shares
Treasury Shares at Period-End1,932 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationFirst quarter
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 February 2026–30 April 2026
Net Sales¥7,488 million (YoY +14.0%)
Operating profit¥2,069 million (YoY +20.8%)
Ordinary income¥2,485 million (YoY +51.5%)
Profit attributable to owners of the parent¥1,855 million (YoY +53.6%)
Net income per share¥57.09
Equity ratioEnd of the current fiscal period 77.9 / End of previous period 76.5
Total assets¥47,174 million
Net assets¥36,761 million
Cash flows from operating activities¥1,776,035 thousand
Cash flows from investing activities¥-2,427,221 thousand
Cash flows from financing activities¥1,119,213 thousand
Cash and cash equivalents at end of period¥7,797,927 thousand
Full-year earnings forecastNet Sales ¥27,000 million (YoY +13.1%) / Operating profit ¥6,000 million (YoY +1.7%) / Ordinary income ¥6,300 million (YoY -11.1%) / Profit attributable to owners of the parent ¥4,600 million (YoY -16.6%)
Annual Dividend Forecast¥35 → ¥35(0.0%)
Segment revenueHigh-Purity Chemical Compounds Business ¥7,488,666 thousand
Regional sales¥1,041,940 thousand, ¥3,018,785 thousand, ¥2,459,526 thousand, ¥690,949 thousand, ¥277,463 thousand
Depreciation and amortization¥604,611 thousand
Disclosure regarding the going concern assumptionNone (the note on the going concern assumption states, “There are no applicable matters.”)
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew 0 companies / Excluded 0 companies / Company name None
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End32,498,640 Shares
Treasury Shares at Period-End1,932 Shares
Factors Behind Changes in Business PerformanceDemand for high-purity chemical compounds used in semiconductor manufacturing increased due to expanded data center investment accompanying the spread of generative AI, sustained investment in advanced logic and memory, and increased inventories held by Chinese customers. Profitability was improved through cost reductions, sales price revisions, and deeper collaboration among group companies and departments, while ordinary income increased due to the recognition of equity-method investment gains and other factors.
Items this document does not state (9)
Operating MarginRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment profitOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Material subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Demand increased due to expanded data center investment accompanying the spread of generative AI, sustained investment in advanced logic and memory, and increased inventories held by Chinese customers. Cost reductions, sales price revisions, and deeper collaboration among group companies and departments also contributed to improved profitability, while ordinary income increased due to the recognition of equity-method investment gains and other factors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Q1 Financial Results for the Fiscal Year Ending January 2027 [Japanese GAAP] (Consolidated) | Tri Chemical Laboratories Inc. (4369) timely disclosure | Komori